documents: FDA-2026-N-10429-0004

Regulatory documents from Regulations.gov including rules, proposed rules, notices, and supporting materials.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id agency_id docket_id title document_type subtype posted_date posted_year posted_month comment_start_date comment_end_date last_modified fr_doc_num open_for_comment withdrawn object_id
FDA-2026-N-10429-0004 FDA FDA-2026-N-10429 Reference 3 - Knuijver, T., Schellekens, A., Belgers, M., Donders, R., van Oosteren, T., et al., ‘‘Safety of ibogaine administration in detoxification of opioid-dependent individuals: a descriptive open-label observational study,’’ Addiction, 117(1):118–128 (2022), available at doi:10.1111/add.15448. Supporting & Related Material Background Material 2026-10-06T04:00:00Z 2026 10     2026-10-06T20:44:33Z   0 0 09000064b9635d76

Links from other tables